 Novel approaches to the treatment of post traumatic stress disorder PTSD in veterans are urgently needed. This proposal seeks to test an innovative approach, one that involves careful pharmacological manipulation of the bodys major stress system, the hypothalamic-pituitary-adrenal HPA axis, using the dose level of the FDA-approved drug, mifepristone 600 mgday. 